COVID-19 and antimicrobial resistance: the next health crisis? Aviva Investors

Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

As the world grapples with COVID-19, antibiotics used to treat serious secondary bacterial infections associated with the coronavirus are making their way into wastewater with potentially dire consequences.

Learn more here

Phone:
01234 388845

Email:
Event enquiries
Finance enquiries
General enquiries
Membership enquiries
Press enquiries
Training enquiries

Address:
226B Oving Road
Chichester
West Sussex
PO19 7EJ

Pensions for Purpose acts as an information centre only. We do not endorse any content published on this website that originated from one of our members. For more information, please see the website terms of use

Tweets by Pensions for Purpose

Keep updated:

COVID-19 and antimicrobial resistance: the next health crisis? Aviva Investors

Abigail Herron, Global Head of Responsible Investment at Aviva Investors, questions whether investors appreciate the seriousness of what antimicrobial resistance could lead to.

Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

Sign up to our newsletter